Literature DB >> 23098536

Silencing of PDK1 gene expression by RNA interference suppresses growth of esophageal cancer.

Jing Yu1, Kui-Sheng Chen, Ya-Nan Li, Juan Yang, Lu Zhao.   

Abstract

The current study was conducted to explore the inhibitory effects of a small interfering RNA (siRNA) on 3-phosphoinositide-dependent protein kinase 1 (PDK1) expression in esophageal cancer 9706 (EC9706) cells and the influence on their biological behavior. After transfection of a synthesized PDK1 siRNA, PDK1 mRNA and protein expression and the phosphorylation level of the downstream Akt protein were assessed using RT-PCR and Western blot analysis. Proliferation, apoptosis, cell invasion and in vivo tumor formation capacity were also investigated using MTT, flow cytometry, Transwell invasion trials, and nude mouse tumor transplantation, respectively. PDK1 siRNA effectively suppressed PDK1 mRNA and protein expression, and down-regulated the phosphorylation level of the Akt protein in the EC9706 cells (P<0.05). It also inhibited cell proliferation and invasion, and promoted apoptosis; such effects were particularly obvious at 48 h and 72 h after transfection (P<0.05). Growth of transplanted tumors was inhibited in nude mice, with decreased PDK1 expression in tumor tissues. PDK1 may be closely correlated with proliferation, apoptosis and invasion of esophageal cancer cells and thus may serve as an effective target for gene therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098536     DOI: 10.7314/apjcp.2012.13.8.4147

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.

Authors:  Lihong Han; Guoxiu Zhang; Nali Zhang; Haiyan Li; Yanyan Liu; Aiguo Fu; Youguang Zheng
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

2.  Upregulation of the long non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage.

Authors:  Chun-Mei Wang; Qing-Quan Wu; Su-Qing Li; Fang-Jun Chen; Lei Tuo; Hai-Wei Xie; Yu-Suo Tong; Lv Ji; Guo-Zhi Zhou; Gang Cao; Ming Wu; Jin Lv; Wei-Hong Shi; Xiu-Feng Cao
Journal:  Dig Dis Sci       Date:  2013-12-12       Impact factor: 3.199

3.  The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts.

Authors:  Joanna Zabkiewicz; Lorna Pearn; Robert K Hills; Rhys G Morgan; Alex Tonks; Alan K Burnett; Richard L Darley
Journal:  Haematologica       Date:  2013-12-13       Impact factor: 9.941

4.  Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.

Authors:  Zhonglu Yang; Zhiyi Wu; Tao Liu; Lei Han; Chunhui Wang; Bo Yang; Fei Zheng
Journal:  Med Oncol       Date:  2014-11-22       Impact factor: 3.064

5.  Down-regulation of succinate dehydrogenase subunit B and up-regulation of pyruvate dehydrogenase kinase 1 predicts poor prognosis in recurrent nasopharyngeal carcinoma.

Authors:  ZhiJian Dai; Shenhua Pan; Congxi Chen; Longhe Cao; Xianhui Li; Xiaofeng Chen; Xiaoqing Su; Sen Lin
Journal:  Tumour Biol       Date:  2015-11-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.